The use of molindone in the treatment of psychotic and delirious patients infected with the human immunodeficiency virus. Case reports.
Four patients with HIV infection and psychosis from various etiologies, refractory to standard treatments, and suffering from severe extrapyramidal symptoms (EPS), had a marked beneficial response to molindone. There was significant control of neuropsychiatric dysfunction without major adverse side effects. The results suggest that further evaluation is warranted of the use of molindone in treating severely ill, psychotic, or delirious HIV-infected patients.
Fernandez
F
F
Baylor College of Medicine, Houston, Texas.
Levy
J K
JK
D015526:AIDS Dementia Complex / Q000188:drug therapy* / Q000503:physiopathology; D000284:Administration, Oral; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D006801:Humans; D008297:Male; D008972:Molindone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology
D014150:Antipsychotic Agents; D008972:Molindone